News
Real-time feed summarized and tagged.
- GlobalNewswire6/9/2026, 8:30:00 PMRobseek Intelligence Inc. Announces Entering into an Agreement and Plan of Merger with QuasarEdge Acquisition Corporation
Robseek Intelligence Inc. has entered into a definitive Agreement and Plan of Merger with QuasarEdge Acquisition Corporation (NYSE: QRED), a SPAC. Under the deal, Robseek will become a wholly owned subsidiary of QuasarEdge's subsidiary, with QuasarEdge merging into that subsidiary to form the surviving publicly traded entity. No financial terms were disclosed in the announcement.
- GlobalNewswire6/9/2026, 12:30:00 PMCycurion, Inc. Completes Transformative Acquisition of Secuvant, LLC and Flagship Panoptic Cybersecurity Platform
Cycurion, Inc. (NASDAQ: CYCU) has completed the acquisition of Secuvant, LLC, the developer of the Panoptic cybersecurity platform, via a merger transaction that closed on June 2, 2026. The deal is described as a strategic move to accelerate Cycurion's growth in AI-driven cybersecurity and managed services. No financial terms of the transaction were disclosed in the announcement.
- GlobalNewswire6/9/2026, 12:00:00 PMVisionWave Brings AI-based Sensing Capabilities for the Defense and Security Sector by Acquiring a Controlling Interest in Foresight Autonomous
VisionWave Holdings (VWAV) has signed a definitive agreement to acquire up to a 52% controlling interest in Foresight Autonomous Holdings (FRSX). The deal is structured as an all-stock transaction, with VisionWave issuing $17.5 million in common shares as consideration. The acquisition is aimed at expanding VisionWave's AI-based sensing capabilities for the defense and security sector.
- SeekingAlpha6/9/2026, 7:02:29 AMGSK to buy Nuvalent for $10.6B
GSK has announced a definitive agreement to acquire Nuvalent for $10.6 billion. The deal represents a significant expansion of GSK's oncology pipeline, targeting Nuvalent's portfolio of precision cancer therapies. No further terms or closing timeline were disclosed in the headline.
Yesterday markets, in your inbox.
Top-discussed tickers and the AI sentiment we read. Not advice.